Medistim ASA reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was NOK 137.39 million compared to NOK 117.5 million a year ago. Net income was NOK 32.92 million compared to NOK 33.12 million a year ago. Basic earnings per share from continuing operations was NOK 1.8 compared to NOK 1.82 a year ago. Diluted earnings per share from continuing operations was NOK 1.8 compared to NOK 1.81 a year ago.
For the six months, sales was NOK 266.65 million compared to NOK 233.62 million a year ago. Net income was NOK 58.58 million compared to NOK 56.85 million a year ago. Basic earnings per share from continuing operations was NOK 3.21 compared to NOK 3.12 a year ago. Diluted earnings per share from continuing operations was NOK 3.2 compared to NOK 3.11 a year ago.